Anti-CCNL1/ ANIA6A/ BM-001 functional antibody

Anti-CCNL1/ ANIA6A/ BM-001 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCNL1/CCNL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1562-Ab-1/ GM-Tg-hg-SE1562-Ab-2Anti-Human CCNL1 monoclonal antibodyHuman
GM-Tg-rg-SE1562-Ab-1/ GM-Tg-rg-SE1562-Ab-2Anti-Rat CCNL1 monoclonal antibodyRat
GM-Tg-mg-SE1562-Ab-1/ GM-Tg-mg-SE1562-Ab-2Anti-Mouse CCNL1 monoclonal antibodyMouse
GM-Tg-cynog-SE1562-Ab-1/ GM-Tg-cynog-SE1562-Ab-2Anti-Cynomolgus/ Rhesus macaque CCNL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1562-Ab-1/ GM-Tg-felg-SE1562-Ab-2Anti-Feline CCNL1 monoclonal antibodyFeline
GM-Tg-cang-SE1562-Ab-1/ GM-Tg-cang-SE1562-Ab-2Anti-Canine CCNL1 monoclonal antibodyCanine
GM-Tg-bovg-SE1562-Ab-1/ GM-Tg-bovg-SE1562-Ab-2Anti-Bovine CCNL1 monoclonal antibodyBovine
GM-Tg-equg-SE1562-Ab-1/ GM-Tg-equg-SE1562-Ab-2Anti-Equine CCNL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1562-Ab-1/ GM-Tg-hg-SE1562-Ab-2; GM-Tg-rg-SE1562-Ab-1/ GM-Tg-rg-SE1562-Ab-2;
GM-Tg-mg-SE1562-Ab-1/ GM-Tg-mg-SE1562-Ab-2; GM-Tg-cynog-SE1562-Ab-1/ GM-Tg-cynog-SE1562-Ab-2;
GM-Tg-felg-SE1562-Ab-1/ GM-Tg-felg-SE1562-Ab-2; GM-Tg-cang-SE1562-Ab-1/ GM-Tg-cang-SE1562-Ab-2;
GM-Tg-bovg-SE1562-Ab-1/ GM-Tg-bovg-SE1562-Ab-2; GM-Tg-equg-SE1562-Ab-1/ GM-Tg-equg-SE1562-Ab-2
Products NameAnti-CCNL1 monoclonal antibody
Formatmab
Target NameCCNL1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCNL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1562-Ag-1Recombinant multi-species CCNL1/ ANIA6A/ BM-001 protein


    Target information

    Target IDGM-SE1562
    Target NameCCNL1
    Gene ID57018,56706,114121,705208,111092016,101087775,514613,100050292
    Gene Symbol and Synonyms2610030E23Rik,ania-6a,ANIA6A,BM-001,Ccnl,CCNL1,cyclin-L1,PRO1073
    Uniprot AccessionQ9UK58,Q9R1Q2
    Uniprot Entry NameCCNL1_HUMAN,CCNL1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000163660
    Target ClassificationN/A

    The target: CCNL1, gene name: CCNL1, also named as ANIA6A, BM-001, PRO1073, ania-6a. Predicted to enable cyclin-dependent protein serine/threonine kinase regulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.